Jacqueline M Lafky Selected Research

Jacqueline M Lafky Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 02/2005
15	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2005
6	Peripheral Nervous System Diseases (PNS Diseases) 10/2023 - 10/2015
3	Fatigue 01/2020 - 11/2017
3	Disease Progression 03/2016 - 04/2005
3	Ovarian Epithelial Carcinoma 01/2009 - 02/2003
2	Acute Pain 10/2023 - 11/2017
2	Pain (Aches) 01/2021 - 11/2017
2	Arthralgia (Joint Pain) 01/2021 - 08/2015
2	Leukemia 01/2019 - 01/2018
2	Vomiting 01/2018 - 07/2016
2	Nausea 01/2018 - 07/2016
2	Ovarian Neoplasms (Ovarian Cancer) 04/2008 - 02/2005
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2021
1	Hot Flashes 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Diarrhea 01/2020
1	Proteinuria 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Dyspareunia 01/2018
1	Lymphedema (Milroy Disease) 12/2017
1	Hypesthesia (Numbness) 11/2017
1	Osteoporosis 03/2016
1	Colonic Neoplasms (Colon Cancer) 03/2016
1	Metabolic Bone Diseases (Osteopenia) 03/2016
1	Back Pain (Backache) 08/2015
1	Fever (Fevers) 08/2015
1	Bone Fractures (Bone Fracture) 08/2015
1	Ischemia 08/2015
1	Adenocarcinoma 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Adenocarcinoma of Lung 01/2013
1	Endometrial Neoplasms (Endometrial Cancer) 05/2006
1	Ascites 01/2006

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2013 - 02/2003
5	ErbB Receptors (EGF Receptor)IBA 01/2009 - 02/2003
4	Aromatase InhibitorsIBA 01/2021 - 04/2005
4	Letrozole (Femara)FDA LinkGeneric 09/2018 - 04/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 11/2017
3	Hormones (Hormone)IBA 09/2018 - 02/2017
3	Estrogens (Estrogen)FDA Link 03/2016 - 04/2005
3	Protein Isoforms (Isoforms)IBA 04/2008 - 02/2005
2	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2020 - 09/2018
2	Estrogen ReceptorsIBA 01/2019 - 05/2006
2	Dehydroepiandrosterone (DHEA)IBA 04/2018 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2018 - 12/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2016 - 10/2015
2	Zoledronic Acid (Zometa)FDA Link 03/2016 - 08/2015
2	Tamoxifen FDA LinkGeneric 08/2015 - 05/2006
2	human ERBB2 proteinIBA 08/2013 - 01/2013
1	Omacor FDA Link 10/2023
1	AcidsIBA 10/2023
1	EstersIBA 10/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2023
1	Testosterone (Sustanon)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 11/2017
1	Olanzapine (Zyprexa)FDA Link 07/2016
1	CalciumIBA 03/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2016
1	Vitamin D FDA LinkGeneric 03/2016
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 03/2016
1	Fluorouracil (Carac)FDA LinkGeneric 10/2015
1	Leucovorin (Folinic Acid)FDA Link 10/2015
1	CreatinineIBA 08/2015
1	Indicators and Reagents (Reagents)IBA 08/2013
1	Trastuzumab (Herceptin)FDA Link 08/2013
1	LigandsIBA 04/2008
1	Antineoplastic Agents (Antineoplastics)IBA 04/2008
1	Epidermal Growth Factor (EGF)IBA 04/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2006
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2006
1	GranulinsIBA 05/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2006
1	SteroidsIBA 05/2006
1	Conditioned Culture MediaIBA 01/2006
1	AntigensIBA 02/2005

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 10/2023 - 08/2013
11	Therapeutics 10/2023 - 04/2005
4	Adjuvant Chemotherapy 01/2019 - 12/2017
1	Salvage Therapy 01/2020
1	Consolidation Chemotherapy 11/2019
1	Cell Transplantation 11/2019
1	Treatment Delay 08/2015